Literature DB >> 32065449

microRNA expression profiles and the potential competing endogenous RNA networks in NELL-1-induced human adipose-derived stem cell osteogenic differentiation.

Liyuan Yu1, Xiao Cen2, Kai Xia1, Xinqi Huang1, Wentian Sun1, Zhihe Zhao1, Jun Liu1.   

Abstract

Studies have indicated that Nel-like molecule-1 (NELL-1) was an osteoblast-specific cytokine and some specific microRNAs (miRNAs) could serve as competing endogenous RNA (ceRNA) to partake in osteogenic differentiation of human adipose-derived stem cells (hASCs). The aim of this study was to explore the potential functional mechanisms of recombinant human NELL-1 protein (rhNELL-1) during hASCs osteogenic differentiation. rhNELL-1 was added to osteogenic medium to activate osteogenic differentiation of hASCs. High-throughput RNA sequencing (RNA-Seq) was performed and validated by real-time quantitative polymerase chain reaction. Gene ontology functional annotation and Kyoto Encyclopedia of Genes and Genomes pathway analysis were performed to detect the functions of differentially expressed miRNAs and genes. Coding-noncoding gene co-expression network and ceRNA networks were constructed to predict the potential regulatory role of miRNAs. A total of 1010 differentially expressed miRNAs and 1762 differentially expressed messenger RNAs (mRNAs) were detected. miRNA-370-3p, bone morphogenetic protein 2 (BMP2), and parathyroid hormone like hormone (PTHLH) were differentially expressed during NELL-1-induced osteogenesis. Bioinformatic analyses demonstrated that these differentially expressed miRNAs and mRNAs enriched in Rap1 signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, Glucagon signaling pathway, and hypoxia-inducible factor-1 signaling pathway, which were important pathways related to osteogenic differentiation. In addition, miRNA-370-3p and has-miR-485-5p were predicted to interact with circ0001543, circ0002405, and ENST00000570267 in ceRNA networks. Based on the gain or loss of functional experiments by transfection, the results showed that miR-370-3p was a key regulator in osteogenic differentiation by targeting BMP2 and disturbing the expression of PTHLH, and participated in NELL-1-stimulated osteogenesis. The present study provided the primary data and evidence for further exploration on the roles of miRNAs and ceRNAs during NELL-1-induced ossification of hASCs.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  MSC; NEL-like 1 protein; RNA sequence analyses; microRNAs; ossification

Mesh:

Substances:

Year:  2020        PMID: 32065449     DOI: 10.1002/jcb.29695

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  circ_0003204 regulates the osteogenic differentiation of human adipose-derived stem cells via miR-370-3p/HDAC4 axis.

Authors:  Liyuan Yu; Kai Xia; Jing Zhou; Zhiai Hu; Xing Yin; Chenchen Zhou; Shujuan Zou; Jun Liu
Journal:  Int J Oral Sci       Date:  2022-06-21       Impact factor: 24.897

Review 2.  The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.

Authors:  Maria Rosa Iaquinta; Carmen Lanzillotti; Chiara Mazziotta; Ilaria Bononi; Francesca Frontini; Elisa Mazzoni; Lucia Oton-Gonzalez; John Charles Rotondo; Elena Torreggiani; Mauro Tognon; Fernanda Martini
Journal:  Theranostics       Date:  2021-04-30       Impact factor: 11.556

3.  METTL3-Mediated lncRNA m6A Modification in the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Induced by NEL-Like 1 Protein.

Authors:  Yidan Song; Yihua Pan; Mengsong Wu; Wentian Sun; Liangyu Luo; Zhihe Zhao; Jun Liu
Journal:  Stem Cell Rev Rep       Date:  2021-09-10       Impact factor: 5.739

Review 4.  Runx2 and Nell-1 in dental follicle progenitor cells regulate bone remodeling and tooth eruption.

Authors:  Li Zeng; Hong He; Mingjie Sun; Xinyi Gong; Mengqi Zhou; Yaya Hong; Yongjia Wu; Xuepeng Chen; Qianming Chen
Journal:  Stem Cell Res Ther       Date:  2022-09-30       Impact factor: 8.079

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.